Antithrombotic effect of clopidogrel in a vena cava thrombosis model in obese mice.
Lijnen
H R
HR
Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium. roger.lijnen@med.kuleuven.be
Helsen
S
S
Hoylaerts
M F
MF
D000818:Animals; D000077144:Clopidogrel; D004041:Dietary Fats / Q000008:administration & dosage; D004195:Disease Models, Animal; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D051379:Mice; D008820:Mice, Obese; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D014684:Venae Cavae; D020246:Venous Thrombosis / Q000188:drug therapy*
D004041:Dietary Fats; D005343:Fibrinolytic Agents; D000077144:Clopidogrel; D013988:Ticlopidine